Quest Diagnostics Incorporated (DGX)

NYQ – Цена в реальном времени. Валюта: USD

190.18

+0.37 (0.19%)

При закрытии: May 12, 2026, 4:00 PM EDT

189.13

-1.05 (-0.55%)

До открытия: May 13, 2026, 7:14 AM EDT

Quest Diagnostics Incorporated (DGX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Quest Diagnostics Incorporated (DGX)

Bullish Quarterly Results: 3 Companies Raising Guidance

Quest Diagnostics: Updating Levels After Q1 Earnings

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Quest Diagnostics Prices $500 Million of Senior Notes

Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings

Видео

Пресс-релизы

Quest Diagnostics Prices $500 Million of Senior Notes

Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers

Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors

Bullish Quarterly Results: 3 Companies Raising Guidance

Quest Diagnostics: Updating Levels After Q1 Earnings

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Quest Diagnostics Prices $500 Million of Senior Notes

Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings

Видео

Пресс-релизы

Quest Diagnostics Prices $500 Million of Senior Notes

Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers

Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors

Search stocks

Quest Diagnostics Incorporated (DGX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Quest Diagnostics Incorporated (DGX)

Bullish Quarterly Results: 3 Companies Raising Guidance

Quest Diagnostics: Updating Levels After Q1 Earnings

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Quest Diagnostics Prices $500 Million of Senior Notes

Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings

Видео

Пресс-релизы

Quest Diagnostics Prices $500 Million of Senior Notes

Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers

Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors

Bullish Quarterly Results: 3 Companies Raising Guidance

Quest Diagnostics: Updating Levels After Q1 Earnings

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Quest Diagnostics Prices $500 Million of Senior Notes

Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings

Видео

Пресс-релизы

Quest Diagnostics Prices $500 Million of Senior Notes

Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers

Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors